List of works - Mariateresa Fulciniti

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

scientific article published in January 2019

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

scientific article

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

scientific article

Deciphering the chronology of copy number alterations in Multiple Myeloma

scientific article published on 26 March 2019

Differential and limited expression of mutant alleles in multiple myeloma

scientific article

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

scientific article

Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells

scientific article published on 16 December 2015

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

scientific article published on January 2014

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

scientific article published on 08 June 2018

Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity

scientific article published on 03 July 2013

Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma

scientific article published on 29 March 2018

PI3K/p110{delta} is a novel therapeutic target in multiple myeloma

scientific article

Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis

scientific article

Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition.

scientific article

Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)

scientific article published on 10 October 2006

The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo

scientific article

List of works by Mariateresa Fulciniti

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Deciphering the chronology of copy number alterations in Multiple Myeloma

Differential and limited expression of mutant alleles in multiple myeloma

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity

Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma

PI3K/p110{delta} is a novel therapeutic target in multiple myeloma

Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis

Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition.

Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)

The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo